Heinrich Heine University Düsseldorf-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

    The Lancet Neurology, Vol. 18, Núm. 9, pp. 845-856